Physician profile
Thomas F Saylor
NPI 1205879350
$3,157.07
in general payments reported to CMS, 2019-2025
21 companies · $1,616 in 2025
The $1,616 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $209 · 2020: $45.93 · 2021: $161 · 2022: $704 · 2023: $80.94 · 2024: $340 · 2025: $1,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,181 · Travel and Lodging: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.54 |
| Travel and Lodging | $856.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $921.04 | 2024-2025 | |
| Conetic Solutions, INC. | $352.68 | 2021-2025 | |
| Arthrex, INC. | $308.66 | 2025 | |
| Axogen | $284.02 | 2020-2022 | |
| Embody, INC. | $265.14 | 2022 | |
| Smith+Nephew, INC. | $179.98 | 2019-2024 | Evos, Evos Mini, Collagenase Santyl |
| Depuy Synthes Sales INC. | $169.17 | 2019-2023 | Monovisc |
| Zimmer Biomet Holdings, INC. | $132.42 | 2022-2025 | A.L.P.S., Affixus |
| Globus Medical, INC. | $81.59 | 2022 | |
| Stryker Corporation | $75.56 | 2024-2025 | Variax, Hoffmann |
| Orthofix Medical, INC. | $72.52 | 2019-2025 | Physio-Stim |
| Ermi LLC | $71.53 | 2022-2024 | |
| Pacira Pharmaceuticals Incorporated | $56.78 | 2024-2025 | Iovera, Zilretta, Exparel |
| Bioventus LLC | $37.21 | 2024-2025 | Exogen Ultrasound Bone Healing System |
| Joint Active Systems, INC. | $25.68 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $23.36 | 2021 | |
| Integra Lifesciences Corporation | $21.92 | 2021 | |
| Vericel Corporation | $20.32 | 2025 | Maci |
| Kerecis Limited | $19.89 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Kowa Pharmaceuticals America, INC. | $19.46 | 2023 | Seglentis |
| Endo Pharmaceuticals INC. | $18.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Saylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.